Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

To block renin activity, a nonapeptide converting-enzyme inhibitor was given to 65 seated hypertensive patients. Depressor responses occurred only when control plasma renin activity exceeded 2 ng of angiotensin I per milliliter per hour and correlated directly in amplitude with control plasma renin activity and with induced increments in activity (P less than 0.001 for both). Depressor responses, like renin activity, were characteristic for renin subgroups as defined by renin-sodium profiling. Before and after sodium deprivation, the nonapeptide reduced diastolic pressure in all patients with high renin (by 17.3 and 19.8 per cent) and most patients with normal renin (by 9.1 and 17.7 per cent). Low-renin patients remained unresponsive. This enzyme blockade may cause bradykinin accumulation. But if, as seems likely, depressor responses are due to blockade of angiotensin II formation, the results indicate that, irrespective of sodium balance, measurements of plasma renin activity reflect its contribution to blood-pressure maintenance. The results suggest broad participation of the renin system in common forms of hypertension.

[1]  J. Laragh,et al.  Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. , 1972, The American journal of medicine.

[2]  J. Laragh Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.

[3]  A. Barger,et al.  The Role of the Renin‐Angiotensin‐Aldosterone System in Cardiovascular Homeostasis in Normal Human Subjects , 1976, Circulation.

[4]  J. Laragh,et al.  Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. , 1976, The American journal of medicine.

[5]  Y. S. Bakhle,et al.  Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung , 1968, Nature.

[6]  R. Tarazi,et al.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.

[7]  D. Streeten,et al.  Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. , 1975, The New England journal of medicine.

[8]  J. Laragh,et al.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. , 1973, The American journal of cardiology.

[9]  J. Laragh,et al.  Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. , 1976, The American journal of medicine.

[10]  J. Stewart,et al.  Inactivation of bradykinin in the pulmonary circulation. , 1968 .

[11]  J. Laragh,et al.  Radioimmunoassay of plasma renin activity. , 1975, Seminars in nuclear medicine.

[12]  B. Rubin,et al.  Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  J. Laragh,et al.  Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. , 1973, The American journal of medicine.

[14]  Y. S. Bakhle,et al.  Inhibition of angiotensin I converting enzyme by venom peptides , 1971, British journal of pharmacology.

[15]  M. Maxwell,et al.  Saralasin bolus test Rapid screening procedure for renin-mediated hypertension , 1975, The Lancet.

[16]  E. G. Erdös,et al.  Angiotensin I converting enzyme. , 1975, Circulation research.

[17]  G. Kelliher,et al.  Central hypotensive activity of dl- and d-propranolol. , 1970, Journal of pharmaceutical sciences.

[18]  A. Barger,et al.  Inhibition of angiotensin conversion and prevention of renal hypertension. , 1975, The American journal of physiology.

[19]  J. Laragh,et al.  Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. , 1974, Progress in cardiovascular diseases.

[20]  R. Colman,et al.  Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. , 1975, The Journal of clinical investigation.

[21]  D. Adams,et al.  Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. , 1976, The Journal of clinical investigation.

[22]  D. B. Evans,et al.  Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals. , 1973, European journal of pharmacology.

[23]  H. Gavras,et al.  Reciprocal relation between renin dependency and sodium dependency in essential hypertension. , 1976, The New England journal of medicine.